Skip to main content

Hexima Ltd Consumer Staples
Consumer Staples Finance

$0.021 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
13 November 2026 at 5:55am
If you were already registered, log in here.
Subject
StockBot
HXL Ann: Proposed issue of securities - HXL

StockBot
HXL Ann: Completion of $10 Million Institutional Placement

StockBot
HXL Ann: Trading Halt

StockBot
HXL Ann: Quarterly Activities Report and Appendix 4C

StockBot
HXL Ann: AusBiotech Invest Presentation

StockBot
HXL Ann: Presenting at AusBiotech

StockBot
HXL Ann: Appointment of Company Secretary

StockBot
HXL Ann: Application for quotation of securities - HXL

StockBot
HXL Ann: Presenting at Switzer Small & Micro-Cap Virtual Investor Day

StockBot
HXL Ann: ACCESS CHINA Biotech Forum

StockBot
HXL Ann: Restricted Securities to be Released from Escrow

StockBot
HXL Ann: Notification regarding unquoted securities - HXL

StockBot
HXL Ann: ASX Small and Mid-Cap Conference Presentation

StockBot
HXL Ann: Review of FY21 - Investor Webinar

StockBot
HXL Ann: Corporate Governance Statement

StockBot
HXL Ann: Review of FY21 - Investor Webinar

StockBot
HXL Ann: Investor Webinar on Today

StockBot
HXL Ann: Appendix 3X

StockBot
HXL Ann: Appointment of Jake Nunn as Non-Executive Director

StockBot
HXL Ann: Annual Report 2021

StockBot
HXL Ann: Appendix 4E

StockBot
HXL Ann: Appendix 4G

StockBot
HXL Ann: China Patent for Pezadeftide Granted

StockBot
HXL Ann: Design Patent for Pezadeftide Commercial Packaging

StockBot
HXL Ann: APMA presentation and investor webinar

StockBot
HXL Ann: Quarterly Activities Report and Appendix 4C

StockBot
HXL Ann: Completion of enrolment in Phase IIb Clinical Trial

StockBot
HXL Ann: Presenting Clinical Data at APMA and Investor Webinar

StockBot
HXL Ann: Grant of European Patent over Pezadeftide

StockBot
HXL Ann: Media Interview and Investor Presentation

StockBot
HXL Ann: ShareCafe Presentation

StockBot
HXL Ann: Hexima receives INN designation for HXP124

StockBot
HXL Ann: Grant of HXP124 Patent

StockBot
HXL Ann: Quarterly Activities Report and Appendix 4C

StockBot
HXL Ann: Hexima to Present at APMA

StockBot
HXL Ann: R&D Webinar on Today

StockBot
HXL Ann: SAB Formation and R&D Video Conference

StockBot
HXL Ann: Half Year Report and Accounts

StockBot
HXL Ann: Statement pursuant to ASX listing rule 4.7C.2

StockBot
HXL Ann: Transcript of Investor 4th Quarter Call

StockBot
HXL Ann: Quarterly Activity Report

StockBot
HXL Ann: Appendix 4C Cash Flow Report

StockBot
HXL Ann: Quarterly Report & Investor Conference Call Updated

StockBot
HXL Ann: Notification of Quarterly Report & Investor Conference Call

StockBot
HXL Ann: Updated timeline to Phase 2B results

StockBot
HXL Ann: Hexima Quarter 3 Newsletter, Nail Mail

StockBot
HXL Ann: Hexima Presentation

StockBot
HXL Ann: Public Offer and Listing Announcement, Hexima Limited

StockBot
HXL Ann: Becoming a substantial holder from GOW

StockBot
HXL Ann: Becoming a substantial holder

If you were already registered, log in here.

Similar Companies

CSL ...
CSL
Clinuvel Pharmaceuticals
CUV
Immutep
IMM
Imugene
IMU
Mesoblast
MSB
Opthea
OPT
Paradigm Biopharmaceuticals
PAR
PYC Therapeutics
PYC
Race Oncology
RAC
Telix Pharmaceuticals
TLX

Upcoming Floats (8)

SUPER MINERALS LTD
S88
MAVERICK URANIUM LIMITED
MAV
Capability X
CX8
MATRIX CRITICAL MINERALS LIMITED
MTX $12m raise
Fitgenes
ATW $7.5m raise
RIO DE ORO CORP LTD
RDO $30m raise
Adbri Ltd
ABC $5m raise
RAMSAY GENERALE DE SANTE SA
RGS
Top